Thursday, 30 April 2020
Phase 3 results on Gilead coronavirus drug encouraging; a look at other potential COVID-19 treatments under trial
California-based biotech company Gilead Sciences and the US government reported that in a major study, remdesivir shortened the time it takes for COVID-19 patients to recover by four days on average
The post Phase 3 results on Gilead coronavirus drug encouraging; a look at other potential COVID-19 treatments under trial appeared first on Firstpost.
from Firstpost https://ift.tt/3aUxp7L
Subscribe to:
Post Comments
(
Atom
)
No comments :
Post a Comment